Organon (OGN) Asset Utilization Ratio (2021 - 2026)
Organon (OGN) recorded quarterly Asset Utilization Ratio of 0.48 in Q1 2026, up 1.28% quarter-over-quarter from 0.47 in Q4 2025, and down 0.59% on a YoY basis from 0.48 in Q1 2025.
Organon (OGN) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Organon's Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.48 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 0.59% year-over-year to 0.48; the TTM figure through Mar 2026 stood at 0.48 (down 0.59% YoY), while the FY2025 annual figure was 0.48, down 5.94% from the prior year.
- Asset Utilization Ratio was 0.48 for Q1 2026 at Organon, up from 0.47 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.6 in Q2 2022 to a low of 0.47 in Q3 2025.
- Historically, Asset Utilization Ratio has averaged 0.53 across 5 years, with a median of 0.53 in 2024.
- The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio grew 5.29% in 2022, then dropped 10.72% in 2025.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.58 in 2022, then declined by 5.94% to 0.54 in 2023, then retreated by 8.77% to 0.5 in 2024, then retreated by 5.0% to 0.47 in 2025, then climbed by 1.28% to 0.48 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.48 (Q1 2026), 0.47 (Q4 2025), and 0.47 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,134,969.93 Bn | 92,134,964.97 Bn | 7.76 Bn | 0.53 |
| 2 | Eli Lilly | 1,027.45 Bn | 1,022.17 Bn | 16.22 Bn | 0.63 |
| 3 | Johnson & Johnson | 559.08 Bn | 537.03 Bn | 15.96 Bn | 0.48 |
| 4 | AbbVie | 394.75 Bn | 385.40 Bn | 10.78 Bn | 0.46 |
| 5 | Merck | 295.12 Bn | 289.47 Bn | 12.09 Bn | 0.50 |
| 6 | Amgen | 186.65 Bn | 174.61 Bn | 5.87 Bn | 0.41 |
| 7 | Gilead Sciences | 159.22 Bn | 151.50 Bn | 5.52 Bn | 0.52 |
| 8 | Pfizer | 146.00 Bn | 133.23 Bn | -1.21 Bn | 0.12 |
| 9 | Bristol Myers Squibb | 113.22 Bn | 102.77 Bn | 8.07 Bn | 0.55 |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn | 0.48 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.48 |
| Dec 31, 2025 | 0.47 |
| Sep 30, 2025 | 0.47 |
| Jun 30, 2025 | 0.47 |
| Mar 31, 2025 | 0.48 |
| Dec 31, 2024 | 0.50 |
| Sep 30, 2024 | 0.51 |
| Jun 30, 2024 | 0.53 |
| Mar 31, 2024 | 0.53 |
| Dec 31, 2023 | 0.54 |
| Sep 30, 2023 | 0.56 |
| Jun 30, 2023 | 0.57 |
| Mar 31, 2023 | 0.57 |
| Dec 31, 2022 | 0.58 |
| Sep 30, 2022 | 0.60 |
| Jun 30, 2022 | 0.60 |
| Mar 31, 2022 | 0.60 |
| Dec 31, 2021 | 0.57 |
| Sep 30, 2021 | 0.57 |
| Jun 30, 2021 | 0.62 |